EMA’s New Clinical Trial Guidelines for Antidepressant Development: Better & Faster Treatments (2023)
The European Medicines Agency (EMA) has updated its guidance on clinical trials for new depression treatments, with the goals of harmonizing standards across the EU and facilitating development of improved therapies. Key Facts: Depression is a highly disabling condition affecting many worldwide, which has been exacerbated by the COVID-19 pandemic Up to 2/3 of patients …
